Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28963242 | 0.96 | ALDH1A1 (0.37) | ALDH1A1CA12CA1CA9CYP2C19 | |
| SCHEMBL31121930 | 0.94 | ALDH1A1 (0.36) | ALDH1A1CYP2C19 | |
| SCHEMBL38651084 | 0.91 | ALDH1A1 (0.38) | ALDH1A1CA12CA1CA9 | |
| SCHEMBL10635589 | 0.86 | ALDH1A1 (0.45) | ALDH1A1 | |
| SCHEMBL16875634 | 0.82 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL29176333 | 0.79 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL29310736 | 0.77 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL23297233 | 0.75 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL28551883 | 0.73 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL31026155 | 0.71 | ALDH1A1 (0.64) | ALDH1A1CA12CA1CA9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226320-A1 | DRUG CONJUGATES WITH SELF-STABILIZING LINKERS HAVING IMPROVED PHYSIOCHEMICAL PROPERTIES | SEAGEN INC (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226320-A1 | DRUG CONJUGATES WITH SELF-STABILIZING LINKERS HAVING IMPROVED PHYSIOCHEMICAL PROPERTIES | CD44, CD47, UACA | ALDH1A1 553/4885CA12 285/4885CA1 526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.